Delivery Order SPE2DB22D1202-SPE2DB25FVJY5
Award Date 8/29/25
Potential Completion Date 9/22/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,434.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rhophylac 300 MCG/2 ML syringes on July 22, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside delivery order represents a pediatric immunoglobulin product sourced through AmerisourceBergen's extensive federal pharmaceutical supply network. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rhophylac 300 mcg/2 mL syringes, with a ceiling value of $10,755.00. The contract, awarded on July 25, 2025, carries a firm fixed price structure with an ultimate completion date of August 15, 2025. This delivery order does not utilize a set-aside designation and represents a competitive award to the prime contractor, whose corporate office is located in Conshohocken, Pennsylvania....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,390.00 firm fixed-price contract is for the supply of 4567321981 ! RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has a ceiling value of $1,434.00 and is a firm fixed price delivery order. The contract has a performance period that runs through July 2, 2025. AmerisourceBergen is a well-established federal contractor, holding a significant Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,147.20, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML medical supplies. The contract has an ultimate completion date of May 27, 2025. AmerisourceBergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, is a critical supplier of medical and pharmaceutical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has a ceiling value of $2,390.00 and is a Firm Fixed Price delivery order with an ultimate completion date of August 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,365.90 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency (DLA) awarded a $1,969.36 delivery order to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order issued under a larger indefinite delivery contract (IDC) vehicle, leveraging the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,386.04 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Fulphila 6 mg/0.6 mL syringes with a ceiling value of $14,031.60 under firm fixed-price terms. The contract, which is not set-aside and was competitively awarded, calls for performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This delivery order represents a child contract issued under...